Archive

A collection of 1068 issues

Latest

Antibiotic plus immunotherapy combination shows activity in F. nucleatum-positive MSS metastatic CRC

Skip to content The CRC Digest ◆ TRIAL DATA Antibiotic plus immunotherapy combination shows activity in F. nucleatum-positive MSS metastatic CRC A multicenter phase 2 trial of 33 patients with Fusobacterium nucleatum-positive, microsatellite-stable metastatic CRC treated with tislelizumab, fruquintinib, and metronidazole achieved a median progression-free survival of 6.0 months, with

Phase III trial shows survival benefit for tyrosine kinase inhibitor plus immunotherapy in pretreated microsatellite-stable colorectal cancer

Skip to content The CRC Digest ◆ TRIAL DATA Phase III trial shows survival benefit for tyrosine kinase inhibitor plus immunotherapy in pretreated microsatellite-stable colorectal cancer — ESMO Gastrointestinal Oncology The interim analysis of the phase III STELLAR-303 trial demonstrated an overall survival benefit with the combination of zanzalintinib (a tyrosine kinase

Silencing DNA repair genes with nanoparticles restores immune response in microsatellite-stable colorectal cancer

Skip to content The CRC Digest ◇ RESEARCH Silencing DNA repair genes with nanoparticles restores immune response in microsatellite-stable colorectal cancer — Molecular Cancer Microsatellite-stable (MSS) colorectal cancer, which represents the majority of cases, typically does not respond to immunotherapy because it has a low tumor mutational burden. Researchers developed lipid nanoparticles

Gut bacteria engineered to convert cholesterol into a tumor-suppressing metabolite show promise in preclinical colorectal cancer models

Skip to content The CRC Digest ◇ RESEARCH Gut bacteria engineered to convert cholesterol into a tumor-suppressing metabolite show promise in preclinical colorectal cancer models — Nature: Colorectal Cancer Researchers identified a cholesterol metabolite called 4-cholesten-3-one (4-C-3) that is depleted in colorectal cancer and can suppress tumor growth by blocking EGFR (epidermal

Subscribe to The CRC Digest

Sign up now to get access to the library of members-only issues.
jamie@example.com
Subscribe